1.Angiogenesis and the Expression of bFGF in Protruded Disc Herniation.
Chang Hoon JEON ; Han Kyeom KIM ; Shin Young KANG
Journal of Korean Society of Spine Surgery 1999;6(1):27-33
There has been suggested to contain neovascularization reported mainly in the extruded and sequestrated disc herniations. This study is the observation of neovascularization of the blood vessels and cells in the protruded disc herniations. The first objective is the observation of the angiogenesis and the bFGF expression in the protruded disc herniations. The second objective is to study the correlation between the age distribution, sex and bFGF expression in the protruded disc herniations. Fourty-eight patients with protruded disc herniation underwent the posterior disectomy at the Ajou university Hospital from Jun. 1994 to Jun 1996. The mean period of postoperative follow-up was 24.5 months. We used the Hematoxylin-eosin stain to confirm the blood vessel formation and a fibroblast growth factor(bFGF) to observe the immunoexpression of the blood vessels and cells in the protruded disc herniation. For the control group, 12 disc specimens were obtained from patients who underwent the anterior interbody fusion for the lumbar burst fracture. The results of staining for the blood vessels or cells were 32 cases in HE stain, and 26 with bFGF. Out of 48 cases, the bFGF expression revealed in 26 cases(54.2%). Neither the correlation between sex and bFGF expression nor age-dependency and bFGF expression was statistically significant(both: chi-square test: p>0.05). The twelve control disc tissues showed the there was no blood vessels in the disc tissues.
Age Distribution
;
Blood Vessels
;
Fibroblast Growth Factors
;
Fibroblasts
;
Follow-Up Studies
;
Humans
2.Serum Fibroblast Growth Factor 21 and New-Onset Metabolic Syndrome: KoGES-ARIRANG Study.
Jung Ran CHOI ; Jang Young KIM ; Il Hwan PARK ; Ji Hye HUH ; Ki Woo KIM ; Seung Kuy CHA ; Kyu Sang PARK ; Joon Hyung SOHN ; Jong Taek PARK ; Sang Baek KOH
Yonsei Medical Journal 2018;59(2):287-293
PURPOSE: Fibroblast growth factor 21 (FGF21) is a crucial metabolic regulator, with multiple favorable effects on glucose homeostasis and lipid metabolism. Since serum FGF21 level has been implicated as a potential marker for the early identification of metabolic syndrome (MetS), we investigated the association between serum FGF21 level and the development of MetS in a population-based prospective study. MATERIALS AND METHODS: We conducted a prospective study of 221 randomly sampled adults without MetS from a general population-based cohort study who were examined from 2005–2008 (baseline) and from 2008–2011 (follow-up). Baseline serum FGF21 levels were analyzed using enzyme-linked immunosorbent assay. RESULTS: During the average 2.8-year follow-up period, 82 participants (36.6%) developed new-onset MetS. Serum FGF21 levels were significantly higher in patients with new-onset MetS than in those without MetS (209.56±226.80 vs. 110.09±81.10, p < 0.01). In multivariate adjusted models, the odds for MetS development were greater in patients with serum FGF21 levels in the highest quartile, compared to those in the lowest quartile (3.84, 95% confidence interval: 1.59–9.28). CONCLUSION: Serum FGF21 level was an independent predictor for new-onset MetS in a population-based prospective study.
Biomarkers/blood
;
Female
;
Fibroblast Growth Factors/*blood
;
Humans
;
Male
;
Metabolic Syndrome/*blood
;
Middle Aged
;
Multivariate Analysis
;
Odds Ratio
;
Prospective Studies
3.Hepatocyte Growth Factor is the Key Cytokine in Stimulating Potential Stem Cells in the Cord Blood into Hepatic Lineage Cells.
Kyung Ha RYU ; Su Jin CHO ; So Youn WOO ; Ju Young SEOH ; Yun Jae JUNG ; Ho Seong HAN
Immune Network 2007;7(3):117-123
BACKGROUND: This study was designed to investigate the role of the hepatocyte growth factor (HGF) with regards to differentiation of somatic stem cells originating from the human umbilical cord blood (UCB) into hepatic lineage cells in vitro culture system. METHODS: Mononuclear cells from UCB were cultured with and without HGF based on the fibroblast growth factor (FGF)-1, FGF-2, and stem cell factor. The cultured cells were confirmed by immunofluorescent staining analysis with albumin (ALB), cytokeratin-19 (CK-19), and proliferating cell nuclear antigen (PCNA) MoAb. ALB and CK-18 mRNA were also evaluated by reverse transcription-polymerase chain reaction. In order to observe changes in proliferating capacity with respect to the cultured period, CFSE with affinity to proliferating cells were tagged and later underwent flow cytometry. RESULTS: In the HGF-treated group, cultured cells had a large oval shaped appearance with adherent, but easily detachable characteristics. In the HGF-non treated group, these cells were spindle-shaped with strong adherent characteristics. Expressions of ALB and CK-19 were evident in HGF-treated group compared to non-expression of those in to HGF-non treated group. Dual immunostaining analysis of the ALB producing cells showed presence of PCNA in their nuclei, and ALB and CK-18 mRNA were detected on the 21st day of cultured cells in the HGF-treated group. CONCLUSION: Our findings suggest that HGF has a pivotal role in differentiating somatic stem cells of human UCB into hepatic lineage cells in vitro.
Cells, Cultured
;
Fetal Blood*
;
Fibroblast Growth Factor 2
;
Fibroblast Growth Factors
;
Flow Cytometry
;
Hepatocyte Growth Factor*
;
Hepatocytes*
;
Humans
;
Keratin-19
;
Proliferating Cell Nuclear Antigen
;
RNA, Messenger
;
Stem Cell Factor
;
Stem Cells*
4.Effect of Ronghuang Granule on serum FGF23, FGFRs and Klotho in non-dialysis patients with CKD-MBD and kidney deficiency and damp-heat syndrome.
Shunjin HU ; Dong WANG ; Rui ZHANG ; Yuanru CAO ; Hua JIN ; Yanping MAO ; Ling WEI ; Kejun REN ; Xuelian ZHANG ; Yiping WANG
Journal of Southern Medical University 2018;38(12):1427-1432
OBJECTIVE:
To observe the effect of Ronghuang granule on serum fibroblast growth factor 23 (FGF23), fibroblast growth factor receptor (FGFRs) and Klotho protein levels in non-dialysis patients with chronic kidney disease-mineral and bone disorder (CKD-MBD) and kidney deficiency and damp heat syndrome.
METHODS:
Seventy non-dialysis CKD-MBD patients with kidney deficiency and dampness-heat syndrome were randomized into control group (=35) and treatment group (=35). All the patients were given routine treatment combined with traditional Chinese medicine retention enema, and the patients in the treatment group received additional Ronghuang granule treatment (3 times a day). After the 12-week treatments, the patients were examined for changes of TCM syndromes. Serum levels of Ca, P, parathyroid hormone (iPTH), FGF23, FGFRs and Klotho proteins were detected before and after treatment. These parameters were also examined in 20 healthy volunteers.
RESULTS:
Sixty-five patients completed the study, including 33 in the control group and 32 in the treatment group. The patients in the treatment group showed significantly better treatment responses than those in the control group ( < 0.05 or 0.01). At 4, 8, and 12 weeks of treatment, the patients in the treatment group had significantly lowered scores of TCM syndromes compared with the score before treatment ( < 0.05 or 0.01), while in the control group, significant reduction of the scores occurred only at 12 weeks ( < 0.05); at each of the time points, the treatment group had significantly greater reductions in the score than the control group ( < 0.01). Significant improvements in serum Ca, P and iPTH levels were observed at 4, 8, and 12 weeks in the treatment group ( < 0.05) but only at 12 weeks in the control group ( < 0.05). The patients in the control and treatment groups all showed elevated serum levels of FGF23, FGFRs and Klotho protein compared with the normal subjects ( < 0.01); FGF23, FGFRs and Klotho levels were significantly reduced in the treatment group ( < 0.05) but remained unchanged in the control group (>0.05), showing significant differences between the two groups.
CONCLUSIONS
Ronghuang granule improves the clinical symptoms of non-dialysis CKD-MBD patients with kidney deficiency and dampness heat syndrome by reducing serum levels of FGF23, FGFRs and Klotho, improving calcium and phosphorus metabolism disorder, and inhibiting secondary hyperparathyroidism.
Calcium
;
blood
;
Chronic Kidney Disease-Mineral and Bone Disorder
;
blood
;
therapy
;
Drugs, Chinese Herbal
;
pharmacology
;
Enema
;
Fibroblast Growth Factors
;
blood
;
Glucuronidase
;
blood
;
Humans
;
Parathyroid Hormone
;
blood
;
Phosphorus
;
blood
;
Receptors, Fibroblast Growth Factor
;
blood
;
Renal Insufficiency, Chronic
;
blood
;
therapy
;
Sweating Sickness
;
blood
;
therapy
;
Syndrome
5.Effect of propranolol gel on plasma VEGF, bFGF and MMP-9 in proliferating infantile hemangiomas of superficial type.
Tang YUJUAN ; Chen SHAOQUAN ; Zhang ZAIZHONG ; Chen SHUMING ; Huang GUOLIANG ; Wang LIE
Chinese Journal of Plastic Surgery 2015;31(4):268-273
OBJECTIVETo investigate the effect of topical propranolol gel on the levels of plasma vascular endothelial growth factor (VEGF), basic fibroblastic growth factor (bFGF) and matrix metalloproteinases-9 (MMP-9) in proliferating infantile hemangiomas (IHs) of superficial type.
METHODS33 consecutive children with superficial IHs were observed pre-treatment, 1 and 3 months after application of topical propranolol gel for the levels of plasma VEGF, MMP-9 and bFGF by enzyme-linked immunosorbent assay (ELISA) in Department of General Surgery of Dongfang Hospital from February 2013 to February 2014. The plasma results of IHs were compared with those of 30 healthy infants. The clinical efficacy in IHs was evaluated by Achauer system. Differences of plasma results between the healthy group and the IHs group pre-treatment were analyzed using Mann-Whitney U-test. Paired sample comparisons of any two time points of pre-treatment, 1 month and 3 months after treatment in IHs were evaluated by Wilcoxon signed-rank test.
RESULTSThe clinical efficiency of topical propranolol gel at 1, 3 months after application were 45.45%, 81.82% respectively. The levels of plasma VEGF and MMP-9 in patients pre- treatment were higher than those in healthy infants [(362.16 ± 27.29) pg/ml vs (85.63 ± 8.14) pg/ml, (1376.41 ± 42.15) pg/ml vs (687.27 ± 44.1) pg/ml, P < 0.05], but the level of bFGF did not show significant difference [(176.03 ± 13.60 ) pg/ml vs (235.94 ± 35.43 ) pg/ml, P > 0. 05 ]. The concentrations of VEGF and bFGF at 1, 3 months after treatment decreased obviously [(271.51 ± 18.59) pg/ml vs (362.16 ± 27.29 ) pg/ml, (135.85 ± 12.66) pg/ml vs (176.03 ± 13.60) pg/ml], 1 month after treatment vs pre-treatment, P < 0.05; (240.80 ± 19.89) pg/ml vs (362.16 ± 27.29) pg/ml, (107.31 ± 5.82) pg/ml vs (176.03 ± 13.60) pg/ml, 3 month after treatment vs pre-treatment, P < 0.05, whereas the levels of plasma MMP-9 declined slightly [(1321.18 ± 48.74) pg/ml vs (1376.41 ± 42.15 ) pg/ml, (1468.68 ± 32.78) pg/ml vs (1376.41 ± 42 2.15 ) pg/ml, P > 0.05 ].
CONCLUSIONSPropranolol gel may suppress the proliferation of superficial infantile bemangiomas by reducing VEGF and bFGF.
Administration, Topical ; Case-Control Studies ; Child ; Enzyme-Linked Immunosorbent Assay ; Fibroblast Growth Factor 2 ; blood ; Gels ; Hemangioma ; blood ; drug therapy ; Humans ; Infant ; Matrix Metalloproteinase 9 ; blood ; Propranolol ; pharmacology ; Time Factors ; Vascular Endothelial Growth Factor A ; blood
6.Significance of residual renal function for phosphate control in chronic hemodialysis patients.
Harin RHEE ; Ji Young YANG ; Woo Jin JUNG ; Min Ji SHIN ; Byung Yoon YANG ; Sang Heon SONG ; Ihm Soo KWAK ; Eun Young SEONG
Kidney Research and Clinical Practice 2014;33(1):58-64
BACKGROUND: The aim of this study was to compare mineral metabolism between anuric and nonanuric chronic hemodialysis patients, and determine the differences in phosphate control between the two groups. METHODS: A total of 77 chronic hemodialysis patients were enrolled in this cross-sectional study from January 2012 to February 2012. Patient demographics, laboratory findings, medication histories, and vascular calcification scores were collected. We divided the patients into anuric and nonanuric groups according to the residual renal function and then compared their clinical features. Multivariate binary regression analysis was used in each group to determine the independent factors related to phosphate control. RESULTS: The mean patient age was 59.27+/-13.95 years, and 57.1% of patients were anuric. In anuric patients, dialysis vintage was significantly longer, but the mean Kt/V was not different between groups. Serum phosphate, fibroblast growth factor (FGF)-23, and Ca/P products were significantly higher, and 1,25(OH)2D3 levels were significantly lower in the anuric patients, although the intact parathyroid hormone and 25(OH)D levels were not different. In anuric patients, LnFGF-23 [hazard ratio (HR) 2.894, 95% confidence interval (CI) 1.294-6.474, P=0.010] was an independent factor predictive of phosphate control. However, in the nonanuric patients, glomerular filtration rate (HR 0.409, 95% CI 0.169-0.989, P=0.047) and blood urea nitrogen (HR 1.090, 95% CI 1.014-1.172, P=0.019) were independent factors predictive of phosphate control. CONCLUSION: In chronic hemodialysis patients, preservation of residual renal function is a significant determinant of phosphate control, and the factors associated with phosphate control is different depending on the residual renal function status. In the anuric patients, FGF-23 is most significantly associated with phosphate control; however, glomerular filtration rate and blood urea nitrogen are more important than FGF-23 in the nonanuric HD patients.
Blood Urea Nitrogen
;
Cross-Sectional Studies
;
Demography
;
Dialysis
;
Fibroblast Growth Factors
;
Glomerular Filtration Rate
;
Humans
;
Metabolism
;
Parathyroid Hormone
;
Renal Dialysis*
;
Vascular Calcification
7.The effect of basic fibroblast growth factor (bFGF) on neovascularization and prefabricated flap survival.
Xukai WANG ; Dong YAN ; Yongquan LIU
Chinese Journal of Plastic Surgery 2002;18(5):278-279
OBJECTIVETo observe the effect of basic fibroblast growth factor (bFGF) on neovascularization and prefabricated flap survival.
METHODSMale New-Zealand rabbits weighting 2.0-2.5 kg were used in this study. The experimental model used a prefabricated neck flap, supplied by the transferred and implanted central vascular bundle of the ear. 9 micrograms bFGF and 0.2 ml of normal saline was instilled in the vascular pedicle of the experimental and the control group respectively. After 1, 2, 3 weeks of operation, the neovascularization was studied by confocal laser scanning microscope (CLSM) and flap survival was observed.
RESULTSThe neovascularization and survival of the prefabricated flap was different in the experimental and the control groups. The experimental group was better than the control group.
CONCLUSIONbFGF treatment improved sprouting of the implanted vessel and the prefabricated flap survival.
Animals ; Fibroblast Growth Factor 2 ; pharmacology ; Graft Survival ; drug effects ; physiology ; Male ; Microscopy, Confocal ; Neovascularization, Physiologic ; drug effects ; Rabbits ; Surgical Flaps ; blood supply ; physiology ; Time Factors
8.Levels and dynamic changes of serum fibroblast growth factor 23 in hypophosphatemic rickets/osteomalacia.
Wei-bo XIA ; Yan JIANG ; Mei LI ; Xiao-ping XING ; Ou WANG ; Ying-ying HU ; Hua-bing ZHANG ; Huai-cheng LIU ; Xun-wu MENG ; Xue-ying ZHOU
Chinese Medical Journal 2010;123(9):1158-1162
BACKGROUNDHypophosphatemic rickets/osteomalacia is a group of diseases characterised by defective mineralization of bone due to hypophosphatemia and low 1,25-dihydroxy vitamin D. To explore the role of fibroblast growth factor 23 (FGF-23) in the regulation of phosphate homeostasis, we measured the circulating concentrations of this growth factor in healthy individuals and in patients with hypophosphatemic rickets/osteomalacia.
METHODSNineteen patients with hypophosphatemic rickets/osteomalacia were included in hypophosphatemic group (HP, 12 female and 7 male, mean age was 30 years), and 19 healthy age-matched individuals served as the control group. Full length FGF-23 fragments were measured by two-site enzyme-linked immunosorbent assay.
RESULTSMean FGF-23 concentrations were significantly higher in the HP group ((87.4 +/- 43.6) pg/ml) compared with the control group ((19.2 +/- 6.16) pg/ml; P < 0.001). In 1 patient with tumour-induced osteomalacia, serum FGF-23 concentrations were 84.1 pg/ml; these concentrations were normalized 2 hours after a hemangiopericytoma resection (7.8 pg/ml). Subsequently, serum 1,25(OH)(2) vitamin D3 concentrations significantly increased from 21.3 pg/ml to 89.3 pg/ml, and serum phosphorus levels were normalized.
CONCLUSIONSSerum FGF-23 concentrations were markedly elevated in patients with hypophosphatemic rickets. FGF-23 plays an important role in the pathogenesis of hypophosphatemic rickets/osteomalacia.
Adolescent ; Adult ; Calcitriol ; blood ; Child ; Child, Preschool ; Enzyme-Linked Immunosorbent Assay ; Familial Hypophosphatemic Rickets ; blood ; Female ; Fibroblast Growth Factors ; blood ; Humans ; Male ; Middle Aged ; Osteomalacia ; blood ; Phosphates ; blood ; Young Adult
9.Mechanisms of the role of fibroblast growth factor 21 in attenuating insulin resistance.
Tong-yu XU ; Wen-fei WANG ; Peng-fei XU ; Qing-yan YUAN ; Shuang-qing LIU ; Tong ZHNAG ; Gui-ping REN ; De-shan LI
Acta Pharmaceutica Sinica 2015;50(9):1101-1106
This study is to evaluate the therapeutic effect of fibroblast growth factor 21 (FGF21) on type 2 diabetic mice model and to provide mechanistic insights into its therapeutic effect. Type 2 diabetic animal model was established with high calorie fat diet and low dose streptozotocin (STZ) injection. Mice were then randomized into 5 groups: model control, FGF21 0.25 and 0.05 μmol x kg(-1) x d(-1) groups, insulin treatment group. Ten age-matched normal KM mouse administered with saline were used as normal controls. Serum glucose, insulin, lipid products and the change of serum and liver tissue inflammation factor levels between five groups of mouse were determined. The results showed that blood glucose, insulin, free fatty acids (FFAs), triglycerides, and inflammatory factor average FGF-21 of type 2 diabetes model group and normal control group were significantly higher (P < 0.01), while compared with insulin group, no difference was significant. Average blood glucose, insulin, blood lipid and inflammatory factor of FGF-21 treatment group compared with type 2 diabetes group was significantly lower (P < 0.01) and insulin group has no difference with the model control group. The results of OGTT and HOMA-IR showed that insulin resistance state was significantly relieved in a dose-dependent manner. Thus, this study demonstrates that FGF-21 significantly remits type 2 diabetic mice model's insulin resistance state and participates in the regulation of inflammatory factor levels and type 2 diabetes metabolic disorders.
Animals
;
Blood Glucose
;
Diabetes Mellitus, Experimental
;
drug therapy
;
Diabetes Mellitus, Type 2
;
drug therapy
;
Diet, High-Fat
;
Fatty Acids, Nonesterified
;
blood
;
Fibroblast Growth Factors
;
pharmacology
;
Insulin
;
blood
;
Insulin Resistance
;
Mice
;
Streptozocin
;
Triglycerides
;
blood
10.Aortic Artery and Cardiac Valve Calcification are Associated with Mortality in Chinese Hemodialysis Patients: A 3.5 Years Follow-up.
Xiao-Nong CHEN ; Zi-Jin CHEN ; Xiao-Bo MA ; Bei DING ; Hua-Wei LING ; Zhong-Wei SHI ; Nan CHEN
Chinese Medical Journal 2015;128(20):2764-2771
BACKGROUNDThis study was to investigate the relationship among aortic artery calcification (AAC), cardiac valve calcification (CVC), and mortality in maintenance hemodialysis (MHD) patients.
METHODSAll MHD patients in Shanghai Ruijin Hospital in July 2011 were included. To follow up for 42 months, clinical data, predialysis blood tests, echocardiography, and lateral lumbar X-ray plain radiography results were collected. Plasma FGF23 level was measured using a C-terminal assay.
RESULTSTotally, 110 MHD patients were involved in this study. Of which, 64 (58.2%) patients were male, the mean age was 55.2 ± 1.4 years old, and the median dialysis duration was 29.85 (3.0-225.5) months. About 25.5% of the 110 MHD patients had CVC from echocardiography while 61.8% of the patients had visible calcification of aorta from lateral lumbar X-ray plain radiography. After 42 months follow-up, 25 (22.7%) patients died. Kaplan-Meier analysis showed that patients with AAC or CVC had a significant greater number of all-cause and cardiovascular deaths than those without. In multivariate analyses, the presence of AAC was a significant factor associated with all-cause mortality (hazard ratio [HR]: 3.149, P = 0.025) in addition to lower albumin level and lower 25-hydroxy Vitamin D (25(OH)D) level. The presence of CVC was a significant factor associated with cardiovascular mortality (HR: 3.800, P = 0.029) in addition to lower albumin level and lower 25(OH)D level.
CONCLUSIONLateral lumbar X-ray plain radiography and echocardiography are simple methods to detect AAC and CVC in dialysis patients. The presence of AAC and CVC was independently associated with mortality in MHD patients. Regular follow-up by X-ray and echocardiography could be a useful method to stratify mortality risk in MHD patients.
Aortic Diseases ; blood ; complications ; Calcinosis ; blood ; complications ; China ; Female ; Fibroblast Growth Factors ; blood ; Follow-Up Studies ; Heart Valve Diseases ; blood ; complications ; Heart Valves ; pathology ; Humans ; Male ; Middle Aged ; Proportional Hazards Models ; Renal Dialysis ; mortality